Cold atmospheric plasma to improve cannulation-site wound healing after extracorporeal life support
Official title: Investigating the Impact of Cold Atmospheric Plasma Treatment on Wound Healing at Cannulation Sites in Patients Following Extracorporeal Life Support
Run by National Taiwan University Hospital · NCT07501897 · Data updated 2026-11-12
This trial will test whether adding cold atmospheric plasma (CAP) to standard wound care helps adults on extracorporeal life support heal cannulation-site wounds faster and with fewer infections.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 65 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | March 12, 2026 |
| Main results expected | October 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT07501897 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who are receiving extracorporeal life support and have a cannulation-site wound requiring wound care, without severe local dermatologic disease or prohibitive coagulopathy and with expected survival beyond 48 hours, are ideal candidates.
✕Probably not a fit
Patients with severe pre-existing skin conditions at the cannulation site, significant coagulopathy that precludes local intervention, those receiving other experimental wound therapies, or those with life expectancy under 48 hours may not benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, controlled trial enrolling adults on extracorporeal life support (ECLS) who have cannulation-site wounds. Participants are randomized 1:1 to receive standard wound care alone or standard care plus topical cold atmospheric plasma (CAP) applied at predefined intervals using a medical device. Outcomes include quantitative bacterial burden (fluorescence imaging and cultures), cytokine analysis of wound exudate, clinical wound-healing scores, wound surface measurements, time to epithelialization, need for surgical debridement, infection incidence, and safety monitoring. The study aims to determine whether CAP reduces biofilm and inflammation and accelerates healing in this high-risk population.
Why it matters
Potential benefit: If successful, CAP could speed wound closure, reduce infection and biofilm burden, and lower the need for additional procedures in ECLS cannulation-site wounds.
How similar studies have gone: Smaller clinical and preclinical studies have shown CAP can reduce bacteria and promote healing in chronic and acute wounds, but its specific use for ECLS cannulation sites is relatively novel and not yet widely studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Receiving extracorporeal life support (ECLS) * Presence of cannulation site wound requiring wound care Exclusion Criteria: * Pre-existing severe dermatological conditions at the cannulation site * Severe coagulopathy precluding local intervention * Concurrent receipt of other experimental wound treatments * Life expectancy \< 48 hours
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Chih-Yang Chan
- Email: chanchihyang@gmail.com
- Phone: +886-975810806
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing saline irrigation and povidone-iodine for preventing infections in emergency surgeries
This study is testing whether using saline irrigation or a povidone-iodine solution before closing surgical incisions can better prevent infections in patients having emergency surgeries.
-
Improving respiratory care for patients having high-risk abdominal surgery
This study is testing whether using a special mouthwash and different amounts of oxygen before surgery can help reduce the chances of pneumonia and infections in patients having major abdominal surgery.
-
Silver foam dressing after cesarean: does it prevent infection as well as standard care?
This trial tests whether a silver-containing foam dressing worn over cesarean incisions is no worse than standard dressings at preventing surgical site infections.
-
Skin staples vs polypropylene skin sutures after elective laparotomy
This trial tests whether skin staples or polypropylene sutures work better for closing the skin after elective abdominal surgery in adults.
-
Hernia Sac Flap Coverage of Mesh in Complex Bony-Edged Ventral Hernias
We’re testing whether using the patient’s own hernia sac as a living flap underneath the mesh helps healing after complex ventral hernia repair when part of the edge is bone.
-
Steri-Strips added to standard wound closure after cesarean delivery
This study tests whether adding Steri-Strips after a C-section helps reduce wound problems for pregnant patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.